 |
• |
structure-based drug design based on nuclear magnetic
resonance (NMR) analysis |
 |
| |
• |
mechanism of anthrax toxin action using X-Ray crystallography |
|
| |
• |
molecular basis of cancer: 1) oncogenic proteins such
as receptors, GTPases, tyrosine kinases, and lipid kinases
and 2) tumor suppressor genes |
|
| |
• |
pathophysiology of inflammatory disorders mediated by
mast cells |
|
| |
• |
molecular basis of auto-immune diseases like lupus:
disease-associated anti-DNA antibodies |
|
| |
• |
thrombosis associated with heart disease
through the study of cell surface protease activated receptors |
|
| |
• |
corneal disease through the study of
the galectin protein family |
|
| |
• |
molecular basis of gene function including
DNA replication, regulation of RNA transcription and RNA
processing |
|